Epidemiological studies investigating the association of angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism with polycystic ovary syndrome (PCOS) produced inconsistent results. To derive a more precise estimation of the relationship between I/D polymorphism and PCOS, we conducted the current meta-analysis.
Materials and methods:
PubMed, Web of Science and CNKI were searched for eligible publications up to 1 February 2012. The association was evaluated under different genetic models.
Results:
Six studies with 1451 cases and 773 controls were finally included in our meta-analysis. The results showed that no significant association between I/D polymorphism and PCOS was observed in the overall population. However, in subgroup analyses stratified by ethnicity, significant association was observed in Caucasians (OR = 1.48, 95% CI, 1.00–2.19 for D vs. I; OR = 1.61, 95% CI, 1.14–2.27 for DD vs. II; OR = 1.43, 95% CI, 1.04–1.97 for DD and DI vs. II), but not in Asians.
Conclusions:
Our meta-analysis suggested that the ACE I/D polymorphism was associated with increased risk of PCOS in Caucasians, but not in Asians. However, considering that the conclusions were based on a relatively small sample size, larger studies involving various ethnic populations should be warranted in future studies to validate our findings.
BrassardMAinMelkYBaillargeonJP. Basic infertility including polycystic ovary syndrome. Med Clin North Am2008; 92: 1163–1192, xi.
2.
GoodarziMOAzzizR. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab2006; 20: 193–205.
3.
PrapasNKarkanakiAPrapasI. Genetics of polycystic ovary syndrome. Hippokratia2009; 13: 216–223.
4.
YoshimuraY. The ovarian renin-angiotensin system in reproductive physiology. Front Neuroendocrinol1997; 18: 247–291.
5.
GanongWF. Blood, pituitary, and brain renin-angiotensin systems and regulation of secretion of anterior pituitary gland. Front Neuroendocrinol1993; 14: 233–249.
6.
SteeleMKGalloRVGanongWF. A possible role for the brain renin-angiotensin system in the regulation of LH secretion. Am J Physiol1983; 245: R805–R810.
7.
PalumboAJonesCLightmanA. Immunohistochemical localization of renin and angiotensin II in human ovaries. Am J Obstet Gynecol1989; 160: 8–14.
8.
HeflerLAGreggAR. Influence of the angiotensinogen gene on the ovulatory capacity of mice. Fertil Steril2001; 75: 1206–1211.
9.
PalumboAPourmotabbedGCarcangiuML. Immunohistochemical localization of renin and angiotensin in the ovary: comparison between normal women and patients with histologically proven polycystic ovarian disease. Fertil Steril1993; 60: 280–284.
10.
MorrisRSWongILHatchIE. Prorenin is elevated in polycystic ovary syndrome and may reflect hyperandrogenism. Fertil Steril1995; 64: 1099–1103.
11.
JaatinenTAMatinlauriIAnttilaL. Serum total renin is elevated in women with polycystic ovarian syndrome. Fertil Steril1995; 63: 1000–1004.
12.
HacihanefiogluBSomunkiranAMahmutogluI. Effect of hypertension therapy with the angiotensin-converting enzyme inhibitor lisinopril on hyperandrogenism in women with polycystic ovary syndrome. Fertil Steril2002; 77: 526–528.
13.
NawanoMAnaiMFunakiM. Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat. Metabolism1999; 48: 1248–1255.
14.
MuscogiuriGChavezAOGastaldelliA. The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention. Curr Vasc Pharmacol2008; 6: 301–312.
15.
PollareTLithellHBerneC. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med1989; 321: 868–873.
16.
LoboRA. What are the key features of importance in polycystic ovary syndrome?Fertil Steril2003; 80: 259–261.
17.
RigatBHubertCAlhenc-GelasF. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest1990; 86: 1343–1346.
18.
RigatBHubertCCorvolP. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res1992; 20: 1433.
19.
StroupDFBerlinJAMortonSC. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA2000; 283: 2008–2012.
20.
KoikaVGeorgopoulosNAPioukaA. Increased frequency of the DI genotype of the angiotensin-I converting enzyme (ACE) and association of the II genotype with insulin resistance in polycystic ovary syndrome. Eur J Endocrinol. Epub ahead of print 5January2012. DOI: 10.1530/EJE-11-0894.
21.
DerSimonianRLairdN. Meta-analysis in clinical trials. Control Clin Trials1986; 7: 177–188.
22.
MantelNHaenszelW. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst1959; 22: 719–748.
23.
CaoYWangYZhouP. Relationship between ACE gene polymorphism and the renin-angiotensin system in PCOS patients. Chinese Journal of Practical Gynecology and Obstetrics2002; 18: 665–666.
24.
CaoYZhuangG. Study on the relationship between polymorphism of the angiotensin-converting-enzyme gene and polycystic ovarian syndrome. Chinese Journal of Practical Gynecology and Obstetrics1999; 15: 726–728.
25.
LiQLiuPXuM. Angiotensin converting enzyme gene polymorphism and angiotensin converting enzyme activity in polycystic ovary syndrome. Hebei Medical Journal2008; 30: 1767.
26.
KarabulutATurgutSTurgutG. Angiotensin converting enzyme gene insertion/deletion polymorphism in patients with polycystic ovary syndrome. Gynecol Endocrinol2010; 26: 393–398.
27.
SunLLvHWeiW. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome. J Endocrinol Invest2010; 33: 77–82.
28.
CelikOYesiladaEHascalikS. Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS. Reprod Biomed Online2010; 20: 492–498.
29.
SunJFanHCheY. Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls. BMC Med Genet2009; 10: 64.
30.
BayramBKilicciCOnluH. Association of angiotensin converting enzyme (ACE) gene I/D polymorphism and polycystic ovary syndrome (PCOS). Gene2011; 489: 86–88.
31.
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod2004; 19: 41–47.
32.
ZawadskiJKDunaifA. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: DunaifAGivensJRHaseltineFPMerriamGEHershmanSM (eds) Polycystic ovary syndrome. Current issues in endocrinology and metabolism. Boston: Blackwell, 1992, pp.377–384.
33.
AzzizRCarminaEDewaillyD. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril2009; 91: 456–488.
34.
AzzizR. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab2006; 91: 781–785.
35.
ZintzarasELauJ. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol2008; 61: 634–645.
